A Selective PPARγ Modulator Reduces Hepatic Fibrosis

A Selective PPARγ Modulator Reduces Hepatic Fibrosis

Hepatic fibrosis is the accumulation of excess collagen as a result of chronic liver injury. If left unabated, hepatic fibrosis can lead to the disruption of the liver architecture, portal hypertension, and increased risk of progression to cirrhosis and hepatocellular carcinoma. The thiazolidinedion...

Full description

Bibliographic Details
Main Authors:	Benita L. McVicker, Frederick G. Hamel, Ronda L. Simpson, Robert G. Bennett
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Biology
Subjects:	hepatic fibrosis peroxisome proliferator-activated receptor gamma cirrhosis
Online Access:	https://www.mdpi.com/2079-7737/9/7/151

Similar Items

Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency[S]
by: Philippe M. Campeau, et al.
Published: (2012-09-01)

Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021-09-01)

Protective effect of apigenin on bleomycin-induced pulmonary fibrosis in mice by increments of lung antioxidant ability and PPARγ expression
by: Xiang Zhou, et al.
Published: (2016-06-01)

MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H<sup>+</sup> Transporting V1 Subunit C1
by: Fei Jing, et al.
Published: (2019-02-01)

Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
by: Raymond L. Konger, et al.
Published: (2021-08-01)

Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells
by: Flora A. Milton, et al.
Published: (2017-08-01)

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
by: Kostadinova Radina, et al.
Published: (2012-10-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
by: Janice V. Huang, et al.
Published: (2012-09-01)

Anluohuaxianwan alleviates carbon tetrachloride-induced hepatic fibrosis in rats through upregulation of peroxisome proliferator-activated receptor-Gamma and downregulation of nuclear factor-Kappa B/IκBα signaling pathway
by: Lin Wang, et al.
Published: (2019-01-01)

<i>Pparγ1 </i>Facilitates ErbB2-Mammary Adenocarcinoma in Mice
by: Xuanmao Jiao, et al.
Published: (2021-04-01)

The Inhibitory Effect of Hydroalcoholic Extract of Black Punica Granatum Pericarp on Melanoma Tumor Angiogenesis through PPARα and PPARγ Pathways in C57BL6 Mice
by: Sima Seifabadi, et al.
Published: (2015-06-01)

Association between γ-glutamyl transpeptidase-to-platelet ratio and hepatic fibrosis in patients with chronic hepatitis B
by: DONG Jingjing, et al.
Published: (2017-03-01)

PPARγ gene expression analysis in psoriasis treatment
by: V. V. Sobolev, et al.
Published: (2021-06-01)

Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
by: Wang X, et al.
Published: (2020-06-01)

Effect of the reduced glutathione antioxidation combined with conventional antiviral drugs on hepatic fibrosis in patient with hepatitis b cirrhosis
by: Sheng-Shui Liu
Published: (2017-08-01)

Pro12Ala substitution in the peroxisome proliferator-activated receptor gamma (PPARγ) gene and non-alcoholic fatty liver disease
by: Chen Shao-Hua, et al.
Published: (2013-01-01)

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
by: Xin Qiao, et al.
Published: (2019-08-01)

There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV
by: A.R. Souza, et al.
Published: (2008-03-01)

The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism
by: Raymond L. Konger, et al.
Published: (2019-06-01)

Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis
by: Wei S, et al.
Published: (2020-10-01)

Crtc1 Deficiency Causes Obesity Potentially via Regulating PPARγ Pathway in White Adipose
by: Yimeng Hu, et al.
Published: (2021-04-01)

Determination of Oxidized Lipids in Commonly Consumed Foods and a Preliminary Analysis of Their Binding Affinity to PPARγ
by: Joanna Skinner, et al.
Published: (2021-07-01)

The Value of Fibrosis Index in Discrimination of Chronic Hepatitis and Cirrhosis
by: Gökhan Söker, et al.
Published: (2017-09-01)

Bexarotene protects against neurotoxicity partially through a PPARγ-dependent mechanism in mice following traumatic brain injury
by: Junchi He, et al.
Published: (2018-09-01)

Seipin knockout in mice impairs stem cell proliferation and progenitor cell differentiation in the adult hippocampal dentate gyrus via reduced levels of PPARγ
by: Guoxi Li, et al.
Published: (2015-12-01)

Deoxynivalenol Exposure Suppresses Adipogenesis by Inhibiting the Expression of Peroxisome Proliferator-Activated Receptor Gamma 2 (PPARγ2) in 3T3-L1 Cells
by: Yurong Zhao, et al.
Published: (2020-08-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Isomer-specific regulation of metabolism and PPARγ signaling by CLA in human preadipocytes
by: J.Mark Brown, et al.
Published: (2003-07-01)

Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis
by: Juan Fu, et al.
Published: (2020-02-01)

Risk factors for liver fibrosis progression in patients with chronic hepatitis C
by: Mercedes de Torres, et al.
Published: (2003-01-01)

Analysis of <i>PPARγ</i> Signaling Activity in Psoriasis
by: Vladimir Sobolev, et al.
Published: (2021-08-01)

Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist
by: Chiara Lucchi, et al.
Published: (2017-09-01)

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
by: Garrido-Gil Pablo, et al.
Published: (2012-02-01)

Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
by: Mebrahtom Gebrelibanos Hiben, et al.
Published: (2020-03-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Trigonella foenum-graecum water extract improves insulin sensitivity and stimulates PPAR and γ gene expression in high fructose-fed insulin-resistant rats
by: Abbas Mohammadi, et al.
Published: (2016-01-01)

The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
by: Xiang Li, et al.
Published: (2019-10-01)

Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPARγ
by: A.O. Mostafa, et al.
Published: (2018-09-01)

Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1
by: XIN Xuan
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_ejb45fmnj50fi5eago9i5l5p7a